Amalgamated Bank’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.28M Sell
27,093
-679
-2% -$141K 0.04% 419
2026
Q1
$6.23M Sell
27,772
-918
-3% -$229K 0.05% 323
2025
Q4
$6.91M Sell
28,690
-2,087
-7% -$534K 0.05% 297
2025
Q3
$8.43M Sell
30,777
-349
-1% -$95.3K 0.06% 245
2025
Q2
$8.03M Sell
31,126
-145
-0.5% -$34.6K 0.06% 244
2025
Q1
$7M Buy
31,271
+117
+0.4% +$27.3K 0.06% 260
2024
Q4
$7.13M Buy
31,154
+1,799
+6% +$433K 0.06% 264
2024
Q3
$7.17M Sell
29,355
-880
-3% -$197K 0.06% 272
2024
Q2
$5.79M Sell
30,235
-1,514
-5% -$307K 0.05% 343
2024
Q1
$6.29M Sell
31,749
-4,196
-12% -$769K 0.05% 347
2023
Q4
$6.18M Sell
35,945
-2,712
-7% -$417K 0.05% 371
2023
Q3
$5.72M Sell
38,657
-1,163
-3% -$210K 0.05% 372
2023
Q2
$8.7M Sell
39,820
-484
-1% -$108K 0.07% 238
2023
Q1
$8.83M Buy
40,304
+715
+2% +$155K 0.08% 230
2022
Q4
$8.24M Buy
39,589
+86
+0.2% +$18.9K 0.07% 248
2022
Q3
$8.62M Buy
39,503
+787
+2% +$179K 0.08% 207
2022
Q2
$8.12M Sell
38,716
-2,243
-5% -$478K 0.08% 225
2022
Q1
$9.93M Buy
40,959
+1,196
+3% +$289K 0.08% 215
2021
Q4
$10.4M Buy
39,763
+6,724
+20% +$1.74M 0.08% 218
2021
Q3
$8.71M Sell
33,039
-1,433
-4% -$392K 0.07% 240
2021
Q2
$8.5M Buy
34,472
+25,645
+291% +$5.39M 0.07% 268
2021
Q1
$1.71M Sell
8,827
-420
-5% -$84.2K 0.06% 300
2020
Q4
$1.97M Sell
9,247
-47
-0.5% -$9.37K 0.07% 246
2020
Q3
$1.59M Sell
9,294
-277
-3% -$51.2K 0.07% 268
2020
Q2
$1.84M Sell
9,571
-14,155
-60% -$2.32M 0.09% 191
2020
Q1
$3.5M Sell
23,726
-769
-3% -$122K 0.09% 194
2019
Q4
$3.8M Buy
24,495
+1,106
+5% +$159K 0.07% 251
2019
Q3
$3.16M Buy
23,389
+4,572
+24% +$599K 0.07% 264
2019
Q2
$2.3M Sell
18,817
-2,307
-11% -$256K 0.05% 339
2019
Q1
$2.2M Buy
21,124
+434
+2% +$44.8K 0.05% 347
2018
Q4
$2.36M Sell
20,690
-575
-3% -$61.6K 0.07% 264
2018
Q3
$2.45M Sell
21,265
-698
-3% -$76.5K 0.06% 295
2018
Q2
$2.27M Sell
21,963
-10,096
-31% -$1.02M 0.06% 325
2018
Q1
$3.16M Buy
32,059
+1,909
+6% +$180K 0.08% 226
2017
Q4
$2.55M Buy
30,150
+1,476
+5% +$122K 0.07% 270
2017
Q3
$2.21M Buy
28,674
+228
+0.8% +$17.4K 0.07% 275
2017
Q2
$2.21M Buy
28,446
+6,007
+27% +$430K 0.07% 255
2017
Q1
$1.61M Sell
22,439
-4,476
-17% -$309K 0.08% 233
2016
Q4
$1.67M Buy
26,915
+2,588
+11% +$159K 0.08% 242
2016
Q3
$1.58M Sell
24,327
-16
-0.1% -$1.06K 0.09% 207
2016
Q2
$1.72M Buy
24,343
+7,033
+41% +$415K 0.1% 190
2016
Q1
$1M Buy
17,310
+1,309
+8% +$74.1K 0.1% 202
2015
Q4
$859K Sell
16,001
-1,111
-6% -$62.6K 0.11% 189
2015
Q3
$872K Buy
17,112
+241
+1% +$13K 0.09% 220
2015
Q2
$951K Buy
16,871
+376
+2% +$23.7K 0.09% 213
2015
Q1
$1.18M Buy
16,495
+565
+4% +$36.7K 0.14% 144
2014
Q4
$893K Buy
15,930
+83
+0.5% +$4.33K 0.14% 149
2014
Q3
$781K Buy
15,847
+134
+0.9% +$6.83K 0.12% 185
2014
Q2
$796K Sell
15,713
-961
-6% -$47.6K 0.12% 176
2014
Q1
$745K Sell
16,674
-120
-0.7% -$5.39K 0.13% 171
2013
Q4
$791K Buy
16,794
+4,317
+35% +$219K 0.13% 164
2013
Q3
$659K Buy
+12,477
New +$605K 0.21% 124

Other funds holding RMD

Amalgamated Bank's RMD Position: Q2 2026 in Review

Amalgamated Bank reduced its ResMed (RMD) stake by 2.4% in Q2 2026, selling an estimated $141K and leaving 27,093 shares worth $5.28M. The position accounts for 0.04% of the portfolio, ranked #419.

Amalgamated Bank first reported a position in RMD in Q3 2013 and has held it in 52 quarters since. The position peaked at $10.4M in Q4 2021. 452 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Amalgamated Bank held 27,093 shares of ResMed worth $5.28M as of Q2 2026.
  • Amalgamated Bank sold 679 ResMed shares in Q2 2026, an estimated $141K.
  • ResMed made up 0.04% of Amalgamated Bank's portfolio in Q2 2026, its #419 holding.
  • Amalgamated Bank first reported a position in ResMed in Q3 2013 and has held it in 52 quarters since.
  • Amalgamated Bank's ResMed position peaked at $10.4M in Q4 2021.
  • 452 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.